(Press-News.org) Chemotherapy remains one of the most powerful tools in the fight against cancer, yet it often comes with significant long-term side effects that can dramatically affect patients’ quality of life. Among the most debilitating is Chemotherapy-Induced Peripheral Neuropathy, which impacts both the central and peripheral nervous systems and affects up to 85% of cancer patients and survivors.
Docetaxel is a chemotherapy drug that kills cancer cells by disrupting microtubules, structures essential for cell division. However, microtubules are also critical for nerve function, so docetaxel can damage nerve endings, axons and mitochondria, causing neuropathic symptoms such as numbness, tingling or pain. While highly effective against advanced, metastatic and chemotherapy-resistant cancers – including androgen-independent prostate cancer – its neurotoxic side effects can be severe enough to force treatment discontinuation.
Like other chemotherapeutics, docetaxel can cause seizures and dose-dependent neuropathy, often reducing nerve signals and slowing conduction, with motor deficits typically more severe than sensory ones, particularly in breast cancer patients.
To better understand these effects, researchers from Florida Atlantic University, in collaboration with Nova Southeastern University, turned to an unlikely ally: Caenorhabditis elegans, a very tiny roundworm with a fully mapped nervous system. Using an electroconvulsive assay, the team simulated seizure-like behaviors in the worms and measured recovery times, creating a controlled platform to study docetaxel-induced neurological dysfunction. They then explored potential treatments to counteract these effects.
The researchers studied two compounds: sildenafil citrate, a well-known drug used to treat pulmonary arterial hypertension and other medical conditions involving impaired blood flow, and Resveramorph-3 (RVM-3), a new experimental compound designed based on the structure of resveratrol, a naturally occurring plant compound.
Results of the study, published in PLOS One, showed that both short-term and long-term exposure to docetaxel significantly delayed recovery from shock-induced seizure-like behavior in C. elegans. These effects parallel the motor and sensory impairments seen in cancer patients receiving taxane chemotherapy, supporting the use of this tiny worm as a model for chemotherapy-induced neurotoxicity. By demonstrating how docetaxel disrupts neuronal function and slows neurological recovery, the study offers insight into the biological basis of these side effects and establishes a system for evaluating potential protective therapies.
Importantly, findings also revealed that sildenafil citrate and RVM-3 significantly improved recovery in the worms. Sildenafil citrate appears to stabilize neuronal activity through protein kinase G signaling and potassium channel regulation, while RVM-3 showed protective effects on nerve cells even after prolonged docetaxel exposure. Both compounds reduced the severity and duration of seizure-like behaviors, suggesting their potential as therapeutic candidates for reducing chemotherapy-related neurotoxicity.
“This study shows that a tiny organism can reveal great insight about a widespread clinical problem,” said Ken Dawson-Scully, Ph.D., senior author and a professor in the Department of Biological Sciences within FAU’s Charles E. Schmidt College of Science. “By using C. elegans, we were able to directly model the neurological side effects of chemotherapy and rapidly test compounds that improve recovery after neurotoxic injury. This approach not only helps us understand how drugs like docetaxel disrupt nerve function, but also provides a powerful, efficient platform for identifying therapies that could one day reduce the debilitating neurological burden experienced by cancer patients.”
Chemotherapy is a cornerstone of cancer treatment worldwide, with an estimated 9.8 million people receiving first-line therapy each year as of 2018. That number is projected to rise to approximately 15 million annually by 2040, reflecting a growing global cancer burden and underscoring the urgent need to better understand and address the side effects of these lifesaving treatments.
“I was very excited by how clearly we could see the neurological effects of chemotherapy and measure recovery in real time,” said Paola Ximena Gonzalez-Lerma, Ph.D., first author, staff scientist in R&D at Allosite Therapeutics, and an FAU Ph.D. graduate who worked in the Dawson-Scully laboratory at Nova Southeastern University where he was a professor in the Department of Psychology and Neuroscience within the College of Psychology. “This platform lets us move quickly from observing nerve dysfunction to testing compounds that restore normal activity, all in a living system. It opens the door to asking questions that would be difficult or slow to address in traditional models, and that’s incredibly motivating as we think about how these findings could translate to more effective neuroprotective strategies.”
This research demonstrates how model organisms can illuminate the mechanisms of complex neurological side effects and provide a practical platform for testing potential treatments.
“Using this platform, our team has laid the groundwork for developing strategies that could allow patients to complete lifesaving chemotherapy while minimizing long-term neurological damage,” said Dawson-Scully, who also serves as provost and vice president for academic affairs at FAU. “These findings represent an important step toward interventions that improve both the effectiveness and tolerability of cancer treatment.”
Study co-authors are Crystal Llyod, PharmD; and Scarlet J. Park, Ph.D., Nova Southeastern University.
- FAU -
About Florida Atlantic University:
Florida Atlantic University serves more than 32,000 undergraduate and graduate students across six campuses along Florida’s Southeast coast. Recognized as one of only 13 institutions nationwide to achieve three Carengie Foundation designations: R1: Very High Research Spending and Doctorate Production,” “Opportunity College and University,” and Carnegie Community Engagement Classification - FAU stands at the intersection of academic excellence and social mobility. Ranked among the Top 100 Public Universities by U.S. News & World Report, FAU is also nationally recognized as a Top 25 Best-In-Class College and cited by Washington Monthly as “one of the country’s most effective engines of upward mobility.” To learn more, visit www.fau.edu.
END
BETHESDA, MD – February 11, 2026 | Bianca Seminotti, PhD is the 2026 recipient of the ACMG Foundation Early Career Travel Award. The ACMG Foundation for Genetic and Genomic Medicine selected Dr. Seminotti based on her abstract “Mitochondrial Function in Fibroblasts from a Patient with Congenital NAD Deficiency due to Biallelic NADSYN1 Variants,” which will be delivered as a platform presentation at the 2026 ACMG Annual Clinical Genetics Meeting.
Dr. Bianca Seminotti earned her bachelor’s degree in Biomedicine and her master’s and doctoral degrees in Biochemistry from ...
Key Takeaways
Rural patients often face greater travel distances when seeking coordinated medical care, which can affect the timeliness and quality of their cancer treatment.
New analysis shows that patients with lung or colon cancer had similar surgical outcomes and mortality rates whether they underwent surgery at a local rural or urban facility.
Study provides preliminary evidence that many rural cancer patients can receive complex surgical care locally to reduce their travel burden, the authors said.
CHICAGO — Adults ...
PULLMAN, Wash. – A wearable biosensor developed by Washington State University researchers could improve wireless glucose monitoring for people with diabetes, making it more cost-effective, accurate, and less invasive than current models.
The WSU researchers have developed a wearable and user-friendly sensor that uses microneedles and sensors to measure sugar in the fluid around cells, providing an alternative to continuous glucose monitoring systems. Reporting in the journal Analyst, the researchers were able to accurately ...
On January 30, 2026, thirty experts and scholars from domestic and international research institutions and universities, along with more than a hundred faculty and students, gathered at the Guanggu Campus of the Wuhan Botanical Garden to celebrate the release of the Journal of Systematics and Evolution (JSE) special issue on Uplift history and biological evolution of the Himalaya (II). The release of this issue, the second volume of the JSE Himalayas Series, also included a journal development seminar and was jointly organized by JSE and the Wuhan Botanical Garden of the Chinese Academy of Sciences.
In addition to promoting ...
In the most comprehensive analysis to date, a new study by Silent Spring Institute identified dozens of hazardous chemicals in hair extensions, including products made from human hair, providing the strongest evidence yet of the potential health risks associated with this largely unregulated category of beauty products that disproportionately affect Black women.
Published in the American Chemical Society journal Environment & Health, the study arrives amid growing concern about the health impacts of hair extensions, which are widely used by Black women. More than 70 percent of Black women report wearing hair extensions ...
After high-profile water crises like the one in Flint, Michigan, some Americans distrust the safety of tap water, choosing to purchase drinking water from freestanding water vending machines or kiosks. Yet this more expensive water may contain different pollutants than local tap water, according to a study in ACS’ Environmental Science & Technology. Researchers report that water sampled from 20 kiosks in six states sometimes contained lead at levels above public health recommendations.
"Currently, water kiosks ...
Numerous potential treatments for neurological conditions, including autism spectrum disorders, have worked well in lab mice but then disappointed in humans. What would help is a non-invasive, objective readout of treatment efficacy that is shared in both species. In a new study in Nature Communications, a team of MIT researchers backed by collaborators across the United States and in the United Kingdom identifies such a biomarker in fragile X syndrome, the most common inherited autism form.
Led by postdoc Sara Kornfeld-Sylla and Picower Professor Mark Bear, the team measured the brainwaves of human boys and men, with or without fragile ...
Penn Engineers have developed a system that lets robots see around corners using radio waves processed by AI, a capability that could improve the safety and performance of driverless cars as well as robots operating in cluttered indoor settings like warehouses and factories.
The system, called HoloRadar, enables robots to reconstruct three-dimensional scenes outside their direct line of sight, such as pedestrians rounding a corner. Unlike previous approaches to non-line-of-sight (NLOS) perception that rely on visible light, HoloRadar works reliably in darkness and under variable lighting conditions.
“Robots ...
Bone repair is a tightly coordinated biological process that relies on stem and progenitor cells to rebuild damaged bone tissue. In younger individuals, these cells rapidly differentiate into osteoblasts—the bone-forming cells that generate new mineralized tissue. With aging, however, this process slows dramatically. Clinicians have long observed that fractures in older adults heal more slowly and are often associated with impaired recovery; however, the molecular signals driving this decline have remained unclear. Understanding why bone regeneration falters with age is critical amid global population aging and rising fracture-related disability.
Against this backdrop, ...
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors’ ability to evade attack by the body’s immune system, a new study shows.
Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the study showed that a key protein — the transcription factor HOXD13 — is essential to the blood vessel growth needed to fuel melanoma tumor cells with oxygen and nutrients. Transcription factors control the rate at which genetic instructions encoded in DNA build the proteins that make up bodily ...
